7,680
Followers
106
Following
698
Posts
N/A
Reels
4
Highlights
8/4
Photos/Videos in last 12
Bio
The Royal Marsden NHS Foundation Trust is a world-leading #cancer centre specialising in cancer diagnosis, treatment, research & education.
-
Avg likes
-
Avg comments
-
Engagement
0.3/wk
Posting
Likes and comments are still being collected for this account. Check back shortly.
#royalmarsden#nhs#cancerresearch#breastcancer#clinicaltrial#rm175#womanshour#wh80#bbcwomanshour#cancer
Recent posts
🌟2026 marks an incredible milestone for The Royal Marsden; 175 years since our hospital first opened its doors and began transforming cancer care.
đź’ś For nearly two centuries, generations of clinicians, researchers, support staff, volunteers, supporters and donors have helped shape a place that is now recognised around the world for its pioneering spirit, ground-breaking discoveries, and unwavering commitment to patients.
🔬Over the next 12 months, we’ll be shining a light on the moments, breakthroughs and people who have made us who we are today - from where it all began, to world firsts in research and treatment, to innovations that changed cancer care forever, to the everyday acts of compassion and kindness that define us.
đź’The Royal Marsden’s legacy lives on through the memories, experiences and contributions of everyone who has worked, volunteered or been cared for here. We’d love to hear your stories - please share your memories using #RM175.
12 Jan 2026
On Friday, Dr Alison Ranger, Consultant Clinical Oncologist at The Royal Marsden, spoke with BBC Woman's Hour, broadcast live on Radio 4.
The segment focused on how safe and beneficial it is for women living with or recovering from cancer to access beauty treatments and massages.
Dr Ranger spoke about the benefits of massages for people living with and beyond cancer, as well as attesting to the lack of evidence behind myths that they can cause cancer to spread through the body.
"At The Royal Marsden we have a complementary therapy service, and we're opening a Centre for Holistic Wellbeing and Recovery, which is funded by The Royal Marsden Cancer Charity, not only to treat our own patients, but to try and disseminate knowledge and expertise across the country and research how these therapies may benefit women."
Listen on @BBCSounds - link in bio
(the segment begins at 10 mins 40 seconds)
@bbcwomanshour #WomansHour #WH80 #bbcwomanshour #royalmarsden #cancer
10 Nov 2026
Today we're recognising the hard work and achievements of all our radiographers at The Royal Marsden in celebration of World Radiography Day, yesterday (8 November)🙌
Radiography is an umbrella term for two different allied professions: Diagnostic radiographers use imaging technology, such as CT scanners and MRIs, in order to examine and diagnose all types of disease in patients, whereas therapeutic radiographers, in addition to using imaging equipment, are also trained to design and deliver radiotherapy treatment to cancer patients, most commonly using linear accelerators.
With their combined expertise, radiographers are a hugely important cornerstone of patients' diagnoses and treatments đź’ś
A big shout out to our fantastic radiography teams in Sutton (top) and Chelsea (bottom)!
#WorldRadiographyDay #radiography #radiographer #royalmarsden #nhs #ahp #cancertreatment #diagnosis
09 Nov 2026
Cancer can affect every aspect of a person’s life.
Breast cancer patient, Grace, speaks about her experience of medical acupunture and how it has given her quality of life đź’ś
Â
Our specialist teams provide expert therapies, practical guidance and emotional support to help you manage symptoms, recover and live as well as possible during treatment and beyond. This whole-person approach recognises the physical, emotional, practical and social impact cancer can have.
Â
#acupuncture #holisticcare #royalmarsden #nhs #breastcancer
06 Nov 2026
New treatment combination shows promising results in recurrent head and neck cancer.
Researchers from The Institute of Cancer Research and The Royal Marsden took part in the global study, which found that amivantamab, given alongside the immunotherapy pembrolizumab and chemotherapy, achieved tumour responses in 77 per cent of patients with HPV-unrelated recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC).
Holly (pictured with her partner Lee and three children), a 30-year-old Royal Marsden patient from County Durham, was diagnosed with stage one tongue cancer in April 2025, while pregnant with her third child. She underwent surgery to remove part of her tongue during pregnancy, followed by surgery to remove lymph nodes in her neck and six weeks of radiotherapy after giving birth. However, a year later, her cancer returned, and she was told it was incurable.
"When I was told my cancer was incurable and that there were no other treatment options available to me at my local hospital, I was desperate to find another way forward," says Holly.
"I contacted Professor Harrington at The Royal Marsden, whose open-minded approach and extensive knowledge gave me hope and made me excited about the possibility of joining the OrigAMI-5 trial. I started the triple-combination treatment in July.
"Scans have already shown a 60 per cent reduction in my cancer and the intense pain I was previously experiencing disappeared within the first few weeks of starting treatment.
"As a mum of three young children, being given another treatment option has meant everything to me. When I thought there was nothing else that could be done, the trial gave me hope."
The OrigAMI-4 trial is supported by The Royal Marsden Cancer Charity (@royalmarsden).
Read the full story - link in bio
#cancerresearch #clinicaltrial #mouthcancerawarenessmonth #tonguecancer #royalmarsden
05 Nov 2026
Alison went from supporting patients at The Royal Marsden to becoming a patient there herself. đź’ś
As the Senior Arts Psychotherapist, Alison spent years helping patients use creativity as a way to express themselves and process their experiences of living with cancer.
In 2020, Alison was diagnosed with an angiosarcoma of the breast and was referred to The Royal Marsden. During her treatment, she used the very same art therapy that she had helped so many others discover, to support herself through her own treatment.
Sadly, Alison passed away in 2022. But her husband, Paul, has found a special way to honour her memory and give back to the hospital that meant so much to them both.
Following his first fundraising motorbike challenge, Paul is got back on the road for a second tour, travelling across Europe in September 2026 to raise money for The Royal Marsden Cancer Charity.
Paul fundraises to keep Alison's memory alive, celebrate the lasting impact she had on so many lives and to help ensure other patients and families can benefit from the world-class treatment, care and research at The Royal Marsden.
Reflecting on why he continues to fundraise, Paul said:
"The Royal Marsden has a world-wide reputation. The work they do has an impact on cancer treatments throughout the UK, and indeed throughout the world... A big thank you to all the staff for the support they give me now but also more importantly the support they gave me when Alison was going through her treatment." đź’¬
Alison is remembered dearly by the colleagues she worked with at The Royal Marsden and all the people she touched through her incredible work.
Thank you, Paul, for keeping Alison's legacy alive and all your continued support. ❤️
Tap the link in bio to find out more about Alison's story (@royalmarsden).
04 Nov 2026
Last week, our wonderful young patients in Sutton and all of our amazing children's unit staff and volunteers took part in a trick or treat event, Halloween lunch and party!
Everyone had a brilliant time, with lots of spooky activities, as well as an inflatable costume race outside the unit where the children in isolation stay, so everyone got to enjoy it!
To all the staff and volunteers, thank you for going above and beyond, sourcing outfits, planning activities, using your creativity and giving the children and families a brilliant opportunity to do something unrelated to cancer treatment.
Carol Etheridge, Senior Physiotherapist, said: "Without the help and enthusiasm of our staff and volunteers this successful event would not have been possible." đź’ś
#halloween #childrenshospital #royalmarsden #nhs #playspecialist #halloweenparty
02 Nov 2026
On Thursday 29 October, Yvette Cooper, Health and Social Care Secretary at the Department of Health and Social Care, visited The Royal Marsden to speak with clinicians, research scientists and patients about our breast cancer research and treatment.
The Secretary of State (SoS) heard about the FAST-Forward Boost trial, led by researchers at the Institute of Cancer Research, and funded by the NIHR (National Institute for Health and Care Research), which is investigating whether a full course of radiotherapy, including an additional tumour-site 'boost' dose, can be safely delivered in just five days rather than up to three weeks which would cut treatment time by up to 75 per cent.
More than 1000 people have joined the FAST-Forward Boost trial, and it has been expanded to 39 hospitals and cancer centres across the UK.
Professor Anna Kirby, Consultant Clinical Oncologist at The Royal Marsden and Professor in Radiotherapy for Breast Cancer at The Institute of Cancer Research, said:
"Reaching 1,000 participants is a fantastic milestone. It reflects the commitment of patients and clinical teams across the UK to answering an important question about how we can improve breast radiotherapy for patients."
Yvette Cooper said: "This trial shows how the UK is using our world beating research capabilities to pursue huge improvements and transformations in cancer treatment for patients in our NHS.
"This programme is aiming to radically shorten the treatment times for breast cancer - to support patients and save more lives. The UK is home to some of the best medical research and clinical expertise in the world, and this trial is the latest example of what we can achieve when we bring them together."
#breastcancer #cancerresearch #clinicaltrial #cancercare #royalmarsden #nhs #dhsc
30 Oct 2026
We’re funding research to dramatically shorten breast cancer radiotherapy treatment.
@yvettecooper.mp visited @royalmarsdennhs to learn about a breakthrough trial, led by @icr_london.
We’ve also appointed former health minister @ashleydalton_mP to advise on delivering our National Cancer Plan.
30 Oct 2026
An immunotherapy drug could help
patients with an advanced form of a
common skin cancer to avoid life-altering
surgery, a recent study has shown.
The study investigated the outcomes
of patients who were treated with
immunotherapy instead of surgery for
advanced cutaneous squamous cell
carcinoma (SCC). The research was
led by Mr Kieran Power (pictured, left), Consultant
Plastic and Reconstructive Surgeon, and Miss Olivia Sharp (pictured, right), Locum Consultant Plastic and Reconstructive Surgeon, from The Royal Marsden’s multidisciplinary Skin Unit.
About 95 per cent of SCC patients can be cured by either surgery or radiotherapy. But a small number have an aggressive, advanced form of the disease, which often affects the head and neck and can involve the underlying muscle, nerves or bone.
These advanced tumours tend to affect
older people who may also have other
serious medical conditions, meaning that
the complex surgery would be risky.
The study showed that 16 (64 per cent) of the 25 patients who took cemiplimab – a drug that helps the immune system to attack cancer cells – saw their tumours shrink by at least 30 per cent.
This included 11 patients (44 per cent) whose tumours disappeared completely. On average, the patients responded to cemiplimab within three weeks, meaning surgery remained an option if needed. As a result, 85 per cent of the patients in the study avoided surgery.
#cancerresearch #clinicaltrial #royalmarsden #nhs #skincancer #immunotherapy
29 Oct 2026
Ruth, an Oxford-based artist and former patient, has painted a portrait of Mr Gui, her Consultant Breast Surgeon, which is on display at The Royal Marsden until the end of October.
The "magnificent" portrait, which was initially painted for an exhibition at The Art Academy in London in 2025, has taken residency at The Royal Marsden, Chelsea, on the staircase above the grand piano throughout October - breast cancer awareness month.
Ruth said: “Mr Gui was the surgeon who treated me when I was diagnosed with breast cancer in 2012. His kindness and reassurance put me at ease during a time of great uncertainty. Painting Mr Gui was a joy. I got to know him better as a person and now consider him a friend.
“I’m indebted to Mr Gui not only for everything he has done for me, but for women everywhere, and the many, many lives that have been saved. I still have my regular mammograms and check-ups, but I have been cancer-free for 15 years.”
Mr Gui said: "Being painted by Ruth, whom I had the privilege of supporting during her cancer journey, was a very special and memorable moment in my career.”
#breastcancerawarenssmonth #breastcancer #artist #surgeon #royalmarsden
28 Oct 2026
NEWS: Adding radiotherapy to standard treatment helped patients with advanced lung cancer live 56% longer without their disease progressing, according to findings from the SARON trial.
Dr Fiona McDonald, Consultant Thoracic Clinical Oncologist at The Royal Marsden, presented the findings at the 2026 European Society for Medical Oncology (ESMO) Congress.
The SARON trial investigated whether adding local consolidation radiotherapy – a type of high-dose radiotherapy – to standard whole-body treatment could improve outcomes for patients with oligometastatic non-small cell lung cancer (NSCLC), which has spread to a small number of sites elsewhere in the body.
Dr McDonald, Chief Investigator of the SARON trial, said:
“Until now, there has been limited randomised evidence about the benefits of adding radiotherapy to the standard of care systemic treatment for patients with oligometastatic non-small cell lung cancer (NSCLC).
"The SARON trial has provided important data in this context, demonstrating a significant improvement in progression-free survival without compromising quality of life.
“It is an exemplar of national collaboration, and these types of studies are crucial for informing personalised treatment approaches for patients.”
To find out more, visit the link in our bio
#theroyalmarsden #esmo #clinicaltrials #lungcancer #radiotherapy #cancerresearch
27 Oct 2026
Follower tracking
We have started recording @royalmarsdennhs, but only 1 observation so far — not enough to show a trend yet. Track it daily →
Download @royalmarsdennhs's data
Everything below is derived from this account, priced on the counts shown. Delivered as CSV by emailed link.
You only pay for rows we deliver. Counts are the maximum available today; if an export comes back smaller, the difference is refunded automatically. Counts as last collected 18Â hours, 34Â minutes ago.
Tracking
A monthly plan, not a download: we keep reading @royalmarsdennhs and email you what changed.
Other reports
Not downloads of this account: they take their own inputs.
Similar accounts
Accounts we track that share hashtags, mentions or bio topics with @royalmarsdennhs.
@icr_london
8,944 followers
Also uses #radiotherapy
@dhscgovuk
28.4K followers
Also mentions @ashleydalton_mp
@isabel.ogara
18.5K followers
Also uses #clinicaltrials
@kennedyframpton
1,961 followers
Also mentions @bbcwomanshour
@yvettecooper.mp
21.6K followers
Also mentions @ashleydalton_mp
@ashleydalton_mp
811 followers
Also mentions @yvettecooper.mp
@officialclaremcdonnell
8,599 followers
Also mentions @bbcwomanshour
@bbcwomanshour
557.7K followers
Also uses #wh80